HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare coverage criteria

This article was originally published in The Gray Sheet

Executive Summary

Town hall meeting originally planned for Aug. 31 to discuss the agency's May 16 "notice of intent" on coverage criteria is rescheduled for Sept. 13. HCFA plans to issue a Federal Register notice the week of Aug. 28 rescinding the earlier date. Issues to be addressed at the town hall meeting include increased evidence burden in coverage reviews and withdrawal of coverage for older technologies. The agency also is expected to announce that it will handle cost issues through its payment division, rather than as part of coverage decisions (1"The Gray Sheet" Aug. 21, 2000, p. 6)

You may also be interested in...



HCFA Expected To Offer Compromise On Cost In Proposed Coverage Criteria

HCFA plans to eliminate or significantly scale back the role of cost from its proposed criteria for making Medicare coverage decisions, according to agency staff.

Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking

Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.

China VBP, Localization And Other Strategies - How Far And Which Way?

Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013787

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel